Clinical studies recruiting near Camperdown

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Phase 3 · Royal Prince Alfred Hospital ( Site 1003) · Merck Sharp & Dohme LLC · NCT06351631 Red Blood Cell Transfusion in ECMO - A Feasibility Trial
NA · Royal Prince Alfred Hospital · Australian and New Zealand Intensive Care Research Centre · NCT05814094 Tissue Repair Gel in Venous Leg Ulcers in AU/US
Phase 3 · Clincial Research Site 62 · TR Therapeutics · NCT06707103 A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · Royal Prince Alfred Hospital · Pfizer · NCT07073820 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Royal Prince Alfred Hospital · Takeda · NCT06671496 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Royal Prince Alfred Hospital · Bristol-Myers Squibb · NCT07291076 A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · Royal Prince Alfred Hospital · Hemab ApS · NCT06754852 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Chris O'Brien LifeHouse · Turning Point Therapeutics, Inc. · NCT03093116 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Chris OBrien Lifehouse · Amgen · NCT04221542 ROADMAP Clinical Trial
Phase 4 · Royal Prince Alfred Hospital · University of Newcastle, Australia · NCT06771050 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Chris OBrien Lifehouse · Amgen · NCT07005128 Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Proto
Phase 3 · Royal Prince Alfred Hospital · Tanabe Pharma America, Inc. · NCT05005975 SNV4818 in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · Chris O'Brien Lifehouse · Pikavation Therapeutics, Inc. · NCT06736704 Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r
Phase 1 · Royal Prince Alfred Hospital · Imugene Limited · NCT03666000 Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Phase 2 · Chris O'Brien Lifehouse · Leiden University Medical Center · NCT05393791 A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Phase 2 · Royal Prince Alfred Hospital · Boehringer Ingelheim · NCT07662122 Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed
Phase 2 · Royal Prince Alfred Hospital · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company · NCT06297226 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785 Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Phase 1 · Chris OBrien Lifehouse · Amgen · NCT07493512 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Royal Prince Alfred Hospital · Hoffmann-La Roche · NCT07351058 A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Trea
Phase 2 · Sydney Local Health District (SLHD) Mental Health · atai Therapeutics, Inc. · NCT06524830 An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Soli
Phase 1 · Chris Obrien Lifehouse · BeOne Medicines · NCT07222267 HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Subo
NA · Royal Prince Alfred Hospital · Concord Repatriation General Hospital · NCT04455932 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · Chris O Brien Lifehouse · Daiichi Sankyo · NCT06203210 Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Phase 1/Phase 2 · Chris O'Brien Lifehouse · ORIC Pharmaceuticals · NCT05315700 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Phase 3 · Chris O'Brien Lifehouse · Revolution Medicines, Inc. · NCT06881784 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Chris OBrien Lifehouse ( Site 3003) · Merck Sharp & Dohme LLC · NCT03486873 Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B R
Phase 3 · Royal Prince Alfred Hospital · Pfizer · NCT05568719 A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · Royal Prince Alfred Hospital · Nordic Lymphoma Group · NCT04332822

Look up another city

Look up another condition